Dyne Therapeutics, Inc. (DYN)
NASDAQ: DYN · Real-Time Price · USD
23.99
-0.31 (-1.28%)
Dec 20, 2024, 4:00 PM EST - Market closed
Dyne Therapeutics Revenue
Revenue (ttm)
n/a
Revenue Growth
n/a
P/S Ratio
n/a
Revenue / Employee
n/a
Employees
141
Market Cap
2.44B
Revenue Chart
Revenue History
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Select Medical Holdings | 6.97B |
Amneal Pharmaceuticals | 2.68B |
Concentra Group Holdings Parent | 1.88B |
Privia Health Group | 1.72B |
Addus HomeCare | 1.13B |
Tandem Diabetes Care | 854.35M |
HUTCHMED (China) | 610.81M |
Catalyst Pharmaceuticals | 460.48M |
DYN News
- 5 weeks ago - Dyne Therapeutics' Q3 Preview: High-Risk, High-Reward Path In Muscle Diseases - Seeking Alpha
- 6 weeks ago - Dyne Therapeutics to Present at Upcoming Investor Conferences - GlobeNewsWire
- 6 weeks ago - The Schall Law Firm Encourages Investor Participation In An Inquiry Into Dyne Therapeutics, Inc. For Possible Securities Law Violations - Accesswire
- 6 weeks ago - Dyne Therapeutics Inc Is Being Investigated For Securities Fraud And Affected Shareholders Are Urged To Contact The Schall Law Firm - Accesswire
- 7 weeks ago - The Schall Law Firm Encourages Investor Participation In A Case Against Dyne Therapeutics, Inc. For Securities Law Violations - Accesswire
- 7 weeks ago - Dyne Therapeutics Inc Is Being Sued For Securities Fraud And Shareholders With Losses Are Urged To Contact The Schall Law Firm - Accesswire
- 7 weeks ago - The Schall Law Firm Encourages Investors To Join A Case Against Dyne Therapeutics, Inc. For Securities Law Violations - Accesswire
- 7 weeks ago - Dyne Therapeutics Inc May Have Committed Securities Fraud And Stockholders With Losses Are Urged To Reach Out To The Schall Law Firm - Accesswire